Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Neogenomics Inc (NASDAQ:NEO)

9.18
Delayed Data
As of Dec 15
 0.00 / 0.00%
Today’s Change
7.12
Today|||52-Week Range
11.63
+7.12%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 4
2016
Quarter 1
2017
Quarter 2
2017
Quarter 3
2017
Revenue and IncomeNet Revenues60.5M61.7M66.1M63.1M
 
 
 
 
 
Cost of Goods Sold27.0M30.5M31.0M30.4M
 
 
 
 
 
Depreciation And Amortization6.2M5.7M5.6M5.5M
 
 
 
 
 
 
Operating ExpensesGross Income27.3M25.5M29.5M27.1M
 
 
 
 
 
General Expenses26.7M25.6M28.2M29.4M
 
 
 
 
 
Research And Development930.0K862.0K947.0K1.3M
 
 
 
 
 
Total Operating Expenses60.0M61.8M64.8M65.4M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income529.0K-115.0K1.3M-2.3M
 
 
 
 
 
Extraordinary Charge-3.5M0.000.000.00
 
 
Interest Expense On Debt5.5M1.4M1.4M1.4M
 
 
 
 
 
Other Expenses0.000.000.00-1.1M
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-8.4M-1.5M-97.0K-4.8M
 
 
 
 
 
Income Taxes-2.2M-825.0K-54.0K-340.0K
 
 
 
 
 
Preferred Dividend-8.0M-2.6M-2.6M-2.7M
 
 
 
 
 
Net Income-6.2M-654.0K-43.0K-5.1M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS78.5M78.7M79.4M79.6M
 
 
 
 
 
Shares To Calculate EPS Diluted78.5M78.7M79.4M79.6M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.18-$0.04-$0.03-$0.10
 
 
 
 
 
EPS Diluted-$0.18-$0.04-$0.03-$0.10